Cargando…

Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma

Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xia, Zhao, Tong, Jiang, Jia-Ning, Liu, Ying, Li, Heming, Wang, Ruo-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799063/
https://www.ncbi.nlm.nih.gov/pubmed/35117368
http://dx.doi.org/10.21037/tcr-20-1936
_version_ 1784641977541722112
author Cheng, Xia
Zhao, Tong
Jiang, Jia-Ning
Liu, Ying
Li, Heming
Wang, Ruo-Yu
author_facet Cheng, Xia
Zhao, Tong
Jiang, Jia-Ning
Liu, Ying
Li, Heming
Wang, Ruo-Yu
author_sort Cheng, Xia
collection PubMed
description Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy for advanced rectal carcinoma 6 months earlier and presented with a mammary mass. An ultrasound-directed core needle biopsy of the breast mass was performed. Cytology indicated an adenocarcinoma with poor to moderate differentiation in the breast mass Immunohistochemistry (IHC) showed cytokeratin (CK) expression with a pattern that is characteristic of colorectal tumours: CK7(−), CK20(+), CDX2(−), Villin(+) TOPOII(−), and a Ki-67 index of 30%. The 3 main breast tumour markers were negative. Based on these histopathological and immunohistochemical findings, the patient was diagnosed with breast metastases from rectal carcinoma. Distant metastasis should be taken into account when a patient has a medical history of rectal adenocarcinoma, even when a rare metastasis site is involved. We should be vigilant when patients have some features that are favorable for metastasis. Histopathological characteristics and immunohistochemical tests are helpful for diagnosis. Regardless of surgical treatment after neoadjuvant chemotherapy, standard chemotherapy regimens for intestinal tumors, and EGFR molecular-targeted drugs, there is no obvious effect and the prognosis is poor. The treatment method needs further study.
format Online
Article
Text
id pubmed-8799063
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87990632022-02-02 Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma Cheng, Xia Zhao, Tong Jiang, Jia-Ning Liu, Ying Li, Heming Wang, Ruo-Yu Transl Cancer Res Case Report Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy for advanced rectal carcinoma 6 months earlier and presented with a mammary mass. An ultrasound-directed core needle biopsy of the breast mass was performed. Cytology indicated an adenocarcinoma with poor to moderate differentiation in the breast mass Immunohistochemistry (IHC) showed cytokeratin (CK) expression with a pattern that is characteristic of colorectal tumours: CK7(−), CK20(+), CDX2(−), Villin(+) TOPOII(−), and a Ki-67 index of 30%. The 3 main breast tumour markers were negative. Based on these histopathological and immunohistochemical findings, the patient was diagnosed with breast metastases from rectal carcinoma. Distant metastasis should be taken into account when a patient has a medical history of rectal adenocarcinoma, even when a rare metastasis site is involved. We should be vigilant when patients have some features that are favorable for metastasis. Histopathological characteristics and immunohistochemical tests are helpful for diagnosis. Regardless of surgical treatment after neoadjuvant chemotherapy, standard chemotherapy regimens for intestinal tumors, and EGFR molecular-targeted drugs, there is no obvious effect and the prognosis is poor. The treatment method needs further study. AME Publishing Company 2020-12 /pmc/articles/PMC8799063/ /pubmed/35117368 http://dx.doi.org/10.21037/tcr-20-1936 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Case Report
Cheng, Xia
Zhao, Tong
Jiang, Jia-Ning
Liu, Ying
Li, Heming
Wang, Ruo-Yu
Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title_full Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title_fullStr Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title_full_unstemmed Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title_short Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
title_sort rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799063/
https://www.ncbi.nlm.nih.gov/pubmed/35117368
http://dx.doi.org/10.21037/tcr-20-1936
work_keys_str_mv AT chengxia rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma
AT zhaotong rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma
AT jiangjianing rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma
AT liuying rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma
AT liheming rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma
AT wangruoyu rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma